• Rydex Biotechnology Fund

Rydex Funds

  • US
  • Health/Biotechnology

Rydex Biotechnology Fund

RYOIX

Summary

The fund seeks capital appreciation by investing in small-and-mid-size companies in the United States.

The investment process is designed to highlight companies that are involved in the biotechnology industry.

The process also includes companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services.

Then the research team combines a proprietary quantitative and qualitative methodology to identify investment opportunities.

The team utilizes screens based on price, liquidity, and tradability to evaluate potential investments.

Then the manager constructs a diversified portfolio of stocks More

Price

Last Close

$62.2 ( -1.95 )

52 Week HL

$107.87 - $60.62

Net Assets

$191 M

Expense Ratio

1.46 %

Sector Allocation

Nov 30, -0001

Top 10 Holdings

Mar 10, 2021

Company Name

  • ABBVIE INC
  • Amgen Inc
  • Gilead Sciences
  • Illumina Inc
  • Vertex, Inc.

Holding

  • 6.81
  • 5.56
  • 4.71
  • 3.71
  • 3.40

Company Name

  • Regeneron Pharmaceuticals
  • Moderna Inc
  • Biogen Inc
  • Corteva INC
  • HORIZON THERAPEUTICS
  • Total

Holding

  • 3.31
  • 3.26
  • 3.25
  • 2.98
  • 2.44
  • 39.43%

Manager

Name

Michael P. Byrum

Leadership

Single Manager

Tenure

2003

Advisor

Documents

Prospectus

Fact Sheet

Q1 2022

Q3 2021

Q2 2021

Annual Reports

Website

Link

Performance

YTD

-19 %

3 Year

-12.86%

5 Year

-0.38%

Best

96.24%
1999

Worst

-45.56%
2002

Returns +
Quarterly

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 -8.3% -1.6% -14.6% 18.5% -0.1% 12.4% -22.5% 13.9% 6.9% 18.3% -
Q2 -12.2% 10.1% 28.3% -3.9% 8.7% 7.7% 1% 7.7% 6.1% 6% -
Q3 - -3.2% 0.5% -8.9% 7.1% 8.4% 13.2% -19.4% 5.4% 16.3% -
Q4 - -18.7% 3.3% 14.8% -18.1% -2.7% -9.2% 10.1% 11.7% 3% -

Returns +
Monthly

J F M A M J J A S O N D
2022 -10.6% -3.9% 6.7% -2.6% -9.3% - - - - - - -
2021 5.3% -2.2% -4.4% 4.3% -3.4% 9.2% -1.6% 3.8% -5.2% 0.3% -4.4% -15.2%

+
Annual

    2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
    0%29%16%29%-6%19%8%-1%14%29%0%

Alpha

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
RYOIX -19%-15%14%--9%30%-20%9%34%-37%
S&P 500 -29%16%29%-6%19%8%-1%14%29%-
Alpha -19%-43%-2%--3%11%-28%9%20%-37%

RYOIX S&P 500

Chart +